ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 6 for:    forty seven inc cancer
Previous Study | Return to List | Next Study

Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02953782
Recruitment Status : Recruiting
First Posted : November 3, 2016
Last Update Posted : March 12, 2018
Sponsor:
Information provided by (Responsible Party):
Forty Seven, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2018
  Estimated Study Completion Date : March 2023